THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

NewAmsterdam Pharma GAAP EPS of -$0. 14 beats by $0. 30, revenue of $19. 16M beats by $4. 11M

This story focuses on NewAmsterdam Pharma GAAP EPS of -$0. 14 beats by $0. 30, revenue of $19. 16M beats by….

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights